Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 12—December 2019
Research Letter

Genetic Characterization of Avian Influenza A(H5N6) Virus Clade 2.3.4.4, Russia, 2018

Author affiliations: State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia

Cite This Article

Abstract

Timely identification of pandemic influenza threats depends on monitoring for highly pathogenic avian influenza viruses. We isolated highly pathogenic avian influenza A(H5N6) virus clade 2.3.4.4, genotype G1.1, in samples from a bird in southwest Russia. The virus has high homology to human H5N6 influenza strains isolated from southeast China.

Highly pathogenic avian influenza (HPAI) H5 virus continues to evolve and pose a threat to animals and humans. Since 2008, HPAI H5 viruses of clade 2.3.4.4 with various neuraminidase (NA) subtypes have become widespread throughout the world and have caused mass epizootics, including in Russia, where these viruses have been reported since 2014 (1). In 2013, H5N6 virus began circulating in China (2), and a case of human disease was recorded there in 2014. Since then, 23 cases of H5N6 infection in humans, including 7 fatalities, have been confirmed in China (3).

In October 2018, we collected cloacal swab samples from aquatic birds around the Volga River Basin in the Saratov region of Russia (51°26′11.7″N, 46°06′49.9″E). We isolated avian H5 influenza virus from 1 sample from a common gull (Larus canus) by using embryonic chicken eggs. We used whole-genome sequencing to extract the virus DNA and conducted a phylogenetic analysis against strains available in the GISAID EpiFlu database (http://www.gisaid.org). We submitted genetic data on the virus, A/common gull/Saratov/1676/2018, to the GISAID EpiFlu database (identification no. EPIISL336925).

Using H5 clade nomenclature designated by the World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization H5 Evolution Working Group (4), our phylogenetic analysis showed that hemagglutinin (HA) gene of A/common gull/Saratov/1676/2018 clusters with HPAI viruses in clade 2.3.4.4 H5N6-H5/Major lineage. Our analyses also show this strain belongs to a new HA subgroup that includes human H5N6 viruses isolated in Guangxi and Guangdong Provinces, China, in 2018 (Appendix Figure 1, Table 1). This subgroup is not represented by existing candidate vaccine viruses (CVVs) (5,6).

The NA gene of A/common gull/Saratov/1676/2018 appears to originate from H6N6 viruses circulating in Asia during 2010–2011 (Appendix Figure 2) and contains the deletion from positions 59–69 in the stalk region. The polymerase basic (PB) 2 gene segment also appears to have originated from an H6 subtype (Appendix Figure 3). The internal gene segments PB1, polymerase (PA), nucleoprotein (NP), matrix (M), and nonstructural protein (NSP) appear to have evolved from HPAI H5 virus clade 2.3.2.1 (Appendix Figures 4–8). The 8-segment constellation leads us to classify this strain into a G1.1 genotype, as described by Bi et al. (6).

We conducted a comparative genomic analysis of A/common gull/Saratov/1676/2018 against H5N6 CVVs; the most pronounced differences were several amino acid substitutions associated with potential changes in antigenic properties. We also detected unique mutations in HA D54N, L115Q, L/Q138T, P141A, N183S, and N189D, including a combination of S121Y and I151T. We noted other mutations, including HA L129S, K/M/T140V (H5 numbering), and NA N86K (N6 numbering), which could be associated with antigenic drift.

A/common gull/Saratov/1676/2018 had an HA polybasic proteolytic cleavage site, PLRERRRKR/G, and showed highly pathogenic properties by killing chicken embryos within 48 hours. We also identified amino acid changes associated with increased virulence to mammals (7,8), including 9 mutations in the PB2 gene, 8 in the PB1 gene, 7 in the NSP gene, 3 in the M gene, 2 in the PA gene, 1 in the HA gene, and 1 in the NA gene, along with the 59–69 deletion, an 80–84 deletion in NS1, and an NS1 ESEV terminal motif. These changes also appear in most H5N6 CVVs (Appendix Table 2).

Comparative analysis of A/common gull/Saratov/1676/2018 against H5N6 CVVs revealed similarity in the presence of genetic elements associated with receptor binding properties. A/common gull/Saratov/1676/2018 and most CVVs had the motif QS(R)G at the receptor-binding site (nt 222–224), which is associated with an avian-like α2,3-SA receptor-binding preference (6). The amino acid changes in D94N, S133A, and T156A in the HA of A/common gull/Saratov/1676/2018 and most H5N6 CVVs are associated with increased binding of the virus to human-like α2,6-SA receptors (7). Our analysis suggests that A/common gull/Saratov/1676/2018 retains its avian status but has several mutations that potentially increase its affinity for α2,6-SA, which could indicate an affinity for both avian- and human-type receptors.

We evaluated the phenotypic properties of the virions by kinetics measurement with surface plasmon resonance to assess their ability to bind to receptor analogs α2,3-SA and α2,6-SA (9). The equilibrium dissociation constant for 3′-Sialyl-N-acetyllactosamine is 12.2 (SD ± 0.7 nmol/L) and for 6′-Sialyl-N-acetyllactosamine is 43.3 (SD ± 2.8 nmol/L) (Appendix). These values show that A/common gull/Saratov/1676/2018 has prevalent affinity for the avian-like receptor with lower, but increased, affinity for the human-like receptor, compared with H5N1 strain A/rook/Chany/32/2015 clade 2.3.2.1.C.

Analysis of homology of A/common gull/Saratov/1676/2018 with H5N6 strains available from GISAID showed that all 8 gene segments clustered with human H5N6 strains isolated in southeast China in 2018. We noted 99% homology with human strain A/Guangxi/32797/2018 for all genes, a genetic similarity that raises the question of which pathway led to the spread of the virus. We believe A/common gull/Saratov/1676/2018 was transferred to eastern Russia through northeast Siberia, where HPAI H5N8 clade 2.3.4.4.A was detected in 2018 (10), the same pathway through which H5N8 virus was transferred from Southeast Asia to Europe. These viral pathogens could be spread by migratory birds over long distances along flyways from southern China to southwestern Russia during a migration season. Our study indicates that emerging H5N6 viruses are a potential threat to public health.

Dr. Susloparov is a senior researcher at the Zoonosis Infections and Influenza Department, State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia. His research interests include the molecular genetics, epidemiology, and host–pathogen interaction of avian influenza viruses.

Top

Acknowledgments

We are grateful to GISAID’s EpiFlu Database (http://www.gisaid.org) and to the authors who provided sequence information.

This research was supported by State Assignment no. 13/19 FBRI SRC VB VECTOR Rospotrebnadzor.

Top

References

  1. Marchenko  V, Goncharova  N, Susloparov  I, Kolosova  N, Gudymo  A, Svyatchenko  S, et al. Isolation and characterization of H5Nx highly pathogenic avian influenza viruses of clade 2.3.4.4 in Russia. Virology. 2018;525:21623. DOIGoogle Scholar
  2. Bi  Y, Liu  H, Xiong  C, Di Liu , Shi  W, Li  M, et al. Novel avian influenza A (H5N6) viruses isolated in migratory waterfowl before the first human case reported in China, 2014. Sci Rep. 2016;6:29888. DOIGoogle Scholar
  3. World Health Organization. Regional Office for the Western Pacific. Avian Influenza Weekly Update Number 671. Geneva: the Organization; 2019 Jan 11 [cited 2019 Jan 11]. https://apps.who.int/iris/bitstream/handle/10665/279855/AI-20190111.pdf
  4. Smith  GJ, Donis  RO. World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5 Evolution Working Group. Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013–2014. Influenza Other Respir Viruses. 2015;9:2716. DOIGoogle Scholar
  5. World Health Organization. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. Geneva: the Organization; February 2019 [cited 2019 Feb 21]. https://www.who.int/influenza/vaccines/virus/201902_zoonotic_vaccinevirusupdate.pdf
  6. Bi  Y, Chen  Q, Wang  Q, Chen  J, Jin  T, Wong  G, et al. Genesis, evolution, and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe. 2016;20:81021. DOIGoogle Scholar
  7. Guo  F, Luo  T, Pu  Z, Xiang  D, Shen  X, Irwin  DM, et al. Increasing the potential ability of human infections in H5N6 avian influenza A viruses. J Infect. 2018;77:34956. DOIGoogle Scholar
  8. Yang  L, Zhu  W, Li  X, Bo  H, Zhang  Y, Zou  S, et al. Genesis and dissemination of highly pathogenic H5N6 avian influenza viruses. J Virol. 2017;91:e0219916. DOIGoogle Scholar
  9. Meng  B, Marriott  AC, Dimmock  NJ. The receptor preference of influenza viruses. Influenza Other Respir Viruses. 2010;4:14753. DOIGoogle Scholar
  10. Verhagen  JH, Herfst  S, Fouchier  RA. Infectious disease. How a virus travels the world. Science. 2015;347:6167. DOIGoogle Scholar

Top

Cite This Article

DOI: 10.3201/eid2512.190504

Original Publication Date: October 31, 2019

Table of Contents – Volume 25, Number 12—December 2019

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Ivan M. Susloparov, State Research Center of Virology and Biotechnology Vector, 630559, Koltsovo, Novosibirsk Region, Russia

Send To

10000 character(s) remaining.

Top

Page created: November 18, 2019
Page updated: November 18, 2019
Page reviewed: November 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external